Next Article in Journal
Resolution of Gastroesophageal Reflux Disease Following Correction for Upper Cross Syndrome—A Case Study and Brief Review
Previous Article in Journal
Extensive Left Ventricular Thrombosis with Concomitant Pulmonary Embolism
Case Report

Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios

1
Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA
2
California State University, Northridge, CA 91330, USA
3
University of California, Irvine, CA 92697, USA
4
Pitzer College, Claremont, CA 91711, USA
*
Author to whom correspondence should be addressed.
Academic Editor: José I. López
Clin. Pract. 2021, 11(2), 309-321; https://doi.org/10.3390/clinpract11020044
Received: 29 March 2021 / Revised: 18 April 2021 / Accepted: 20 April 2021 / Published: 19 May 2021
As the world continues to suffer from an ever-growing number of confirmed cases of the SARS-CoV-2 novel coronavirus, researchers are at the forefront of developing the best plan to overcome this pandemic through analyzing the pathogenesis, prevention, and treatment options pertaining to the virus. In the midst of a pandemic, the main route for detection of the virus has been conducting antigen tests for rapid results, using qRT-PCR, and conducting more accurate molecular tests, using rRT-PCR, on samples from patients. Most common treatments for those infected with COVID-19 include Remdesivir, an antiviral, dexamethasone, a steroid, and rarely, monoclonal antibody treatments. Although these treatments exist and are used commonly in hospitals all around the globe, clinicians often challenge the efficacy and benefit of these remedies for the patient. Furthermore, targeted therapies largely focus on interfering with or reducing the binding of viral receptors and host cell receptors affected by the SARS-CoV-2 novel coronavirus. In addition to treatment, the most efficacious method of preventing the spread of COVID-19 is the development of multiple vaccines that have been distributed as well as the development of multiple vaccine candidates that are proving hopeful in preventing severe symptoms of the virus. The exaggerated immune response to the virus proves to be a worrying complication due to widespread inflammation and subsequent clinical sequela. The medical and scientific community as a whole will be expected to respond with the latest in technology and research, and further studies into the pathogenesis, clinical implications, identification, diagnosis, and treatment of COVID-19 will push society past this pandemic. View Full-Text
Keywords: SARS-COV-2; pathophysiology; treatment; COVID-19; prevention; diagnosis; clinical; case report SARS-COV-2; pathophysiology; treatment; COVID-19; prevention; diagnosis; clinical; case report
Show Figures

Figure 1

MDPI and ACS Style

Tellez, D.; Dayal, S.; Phan, P.; Mawley, A.; Shah, K.; Consunji, G.; Tellez, C.; Ruiz, K.; Sabnis, R.; Dayal, S.; Venketaraman, V. Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios. Clin. Pract. 2021, 11, 309-321. https://doi.org/10.3390/clinpract11020044

AMA Style

Tellez D, Dayal S, Phan P, Mawley A, Shah K, Consunji G, Tellez C, Ruiz K, Sabnis R, Dayal S, Venketaraman V. Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios. Clinics and Practice. 2021; 11(2):309-321. https://doi.org/10.3390/clinpract11020044

Chicago/Turabian Style

Tellez, Daniel; Dayal, Sujay; Phan, Phong; Mawley, Ajinkya; Shah, Kush; Consunji, Gabriel; Tellez, Cindy; Ruiz, Kimberly; Sabnis, Rutuja; Dayal, Surbi; Venketaraman, Vishwanath. 2021. "Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios" Clin. Pract. 11, no. 2: 309-321. https://doi.org/10.3390/clinpract11020044

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop